Dr. Daniel J Burdick MD
Neurologist | Neurology
1959 Ne Pacific St Uwmc Neurology Seattle WA, 98195About
Dr. Daniel Burdick is a distinguished Neurologist in Seattle, WA. Dr. Burdick specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Burdick employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Burdick is committed to staying abreast of the latest developments in neurological research and therapies.
Education and Training
Johns Hopkins University School of Medicine, M.D.
Johns Hopkins University School of Medicine 2006
Board Certification
SurgeryAmerican Board of SurgeryABS
Provider Details
Expert Publications
Data provided by the National Library of Medicine- N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship.
- N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety.
- Predictors of functional impairment in residents of assisted-living facilities: the Maryland Assisted Living study.
- Structure-based design of thienobenzoxepin inhibitors of PI3-kinase.
- Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling.
- Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations.
- Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa.
- Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor.
- Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutation.
- A case of tremor in Klinefelter syndrome worsened by testosterone administration.
- Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors.
- Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR.
- Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains.
- GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2).
- Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
Clinical Trials
Treatments
- Parkinson's Disease
- Tremors
- Abnormal Gait
Fellowships
- University of Washington/Dept of Neurology
Dr. Daniel J Burdick MD's Practice location
Dr. Daniel J Burdick MD's reviews
Write ReviewPatient Experience with Dr. Burdick
Recommended Articles
- The Battle with Insurance for Duchenne Muscular Dystrophy Coverage
With FDA approval of Duchenne therapies, it's not far off to believe that insurance companies would change their policies and make insurance coverage for these therapies easy. However, there is still is an increasing rate of denials from insurance companies for life-saving treatments and medical...
- 8 Multiple Sclerosis Facts You Should Know
Many of us are familiar with the basic facts of multiple sclerosis. We understand that it is an autoimmune disease that affects the central nervous system, brain and spinal cord and in some cases leads to paralysis. But beyond that, MS is a complex disease that millions of people are living and...
- 5-Year-Old with Spinal Muscular Atrophy Can Give Everyone a Little Faith
While many girls her age are just starting kindergarten, 5-year-old Faith is managing a disease called spinal muscular atrophy. And, little Faith Fortenberry's story is a little different than most.While fighting the troubling effects of SMA, she has been taking Spinraza, which has helped her battle...
- Casey's General Stores Continues their Partnership with the Muscular Dystrophy Association
Casey's General Stores announced that they would partner with the Muscular Dystrophy Association (MDA) once again to send kids with muscular dystrophy and other related diseases to summer camp. This partnership has been a tradition for more than 11 years, and helps muscular dystrophy patients offer...
- World Duchenne Awareness Day: September 7th, 2017
Next month, it is World Duchenne Awareness Day and anyone can join the Duchenne community in celebrating it. Duchenne Muscular Dystrophy (DMD) affects 250,000 people in the world, and the disease affects one in every 3,500 boys. People all across the world will raise money and awareness through...
- Researchers Understand More About Why Brain Cells Die in Parkinson's Disease
One of the significant hurdles in finding the treatment of any of the neurodegenerative diseases is the limited knowledge regarding the underlying mechanism. It is known that Parkinson’s and many other neurodegenerative disorders occur due to the buildup of malformed proteins. In the case of...
Nearby Providers
- Mrs. Sujata C. Poisson M.D.400 S 43RD ST RENTON WA 98055
- Dr. Allen Scott Nielsen MD1100 9th Ave Seattle WA 98101
- John W Miller OtherHarborview Medical Center Seattle WA 98104
- Dr. Natalia Murinova M.D.1959 NE Pacific St Seattle WA 98195
- Dr. Rosalind S Chuang M.D.1959 Ne Pacific St Seattle WA 98195
- Dr. Tara L Benkers MD1959 Ne Pacific St Seattle WA 98195